Instrumento Inactivo

Otros idiomas Oramed Pharmaceuticals, Inc. OTC Bulletin Board

Acciones

US68403P1049

Precio de cierre OTC Bulletin Board Otros sitios de cotización
- ^USD	-

12/06	Scilex Holding firma una carta de compromiso para una financiación de 100 millones de dólares; las acciones avanzan antes de salir al mercado	MT
10/06	Oramed Pharmaceuticals Inc. Nombra al Sr. Avraham Gabay Tesorero y Secretario, con efecto a partir del 18 de junio de 2024	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Scilex Holding Signs Commitment Letter for $100 Million Financing; Shares Advance Premarket	12/06
Oramed Pharmaceuticals Inc. Appoints Mr. Avraham Gabay as Chief Financial Officer, Effective as of June 18, 2024	10/06
Oramed Pharmaceuticals Inc. Appoints Mr. Avraham Gabay as Treasurer and Secretary, Effective as of June 18, 2024	10/06
Compugen Names David Silberman CFO	15/05
Oramed Pharmaceuticals Inc. Announces Resignation of David Silberman as Chief Financial Officer, Effective July 12, 2024	13/05
Oramed Pharmaceuticals Inc. Announces Resignation of David Silberman as Treasurer and Secretary, Effective July 12, 2024	13/05
Oramed Pharmaceuticals : Management Change/Compensation - Form 8-K	13/05
Oramed: Q1 Earnings Snapshot	10/05
Oramed Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
Oramed Pharmaceuticals : Update on the receipt of payments for the Scilex transaction	06/05
Oramed Pharmaceuticals : 13D-Nadav Kidron	26/03
Oramed Pharmaceuticals : Update on the receipt of payments for the Scilex transaction	19/03
Oramed Pharmaceuticals Inc. Appoints Yehuda Reznick as Director, Effective as of April 1, 2024	19/03
Oramed Pharmaceuticals : Other Report or Announcement	18/03
Oramed Pharmaceuticals : Other Report or Announcement	18/03
Oramed Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	06/03
Oramed Pharmaceuticals Inc. Announces Resignation of Yadin Rozov from the Board of Directors	19/01
Oramed Pharmaceuticals : Other Report or Announcement	02/01
Oramed Pharmaceuticals : Other Report or Announcement	24/12
Oramed Pharmaceuticals Inc. Appoints Daniel Aghion as Director, Effective January 1, 2024	19/12

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Oramed Pharmaceuticals, Inc. OTC Bulletin Board

Acciones

US68403P1049

Otros idiomas

Filtros